Whole cell Pertussis

2nd ROUND PUBLIC CONSULTATION - UP UNTIL 17 JANUARY 2014

• WHO Regulatory Risk Evaluation on Finding an Adventitious Agent in a Marketed Vaccine
  pdf, 395kb
• Comment form
  doc, 64kb

NEW PUBLICATIONS

• Technical Report Series
  WHO Expert Committee on Biological Standardization: TRS 977-60th report, TRS 978-61st report and TRS 979-62nd report

• Update of WHO biosafety risk assessment and guidelines for the production and quality control of human influenza vaccines against avian influenza A(H7N9) virus
  pdf, 609kb
• WHO Manual for Quality Control of Diphtheria, Tetanus and Pertussis Vaccines

RECENT PUBLICATIONS

WHO Informal Consultation on Recommendations to Assure the Quality, Safety and Efficacy of Poliomyelitis Vaccine, Inactivated (IPV)

Geneva, Switzerland, 25-26 March 2014

WHO implementation Workshops: Evaluation of biotherapeutic products and Evaluation of similar biotherapeutic products with emphasis on monoclonal antibody products

Seoul, Republic of Korea, 13-16 May 2014

CONTACTS

Quality, Safety and Standards (QSS)
Immunization, Vaccines and Biologicals (IVB)
World Health Organization (WHO)
Avenue Appia 20
1211 Geneva 27, Switzerland
Fax No. +41 22 7914971